Clinical Trial

Endarterectomy Versus Stenting in Patients With Symptomatic Severe Carotid Stenosis - 2

Study acronym: EVA3S-2
Recruiting
View on ClinicalTrials.gov →
Summary
Carotid stenosis caused by atherosclerosis is a significant risk factor for ischemic stroke, accounting for up to 15% of all strokes and transient ischemic attacks. Randomized clinical trials (RCTs) have demonstrated the benefits of carotid endarterectomy (CEA) in reducing stroke risk in patients with severe symptomatic carotid stenosis. Carotid artery stenting (CAS) has been developed as an alternative to CEA, offering several potential advantages, such as avoiding local surgical complications. However, unlike CEA, CAS has not been compared to medical therapy in RCTs for symptomatic carotid stenosis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-07; most recent amendment 2025-07-23.
Status change: Not Yet Recruiting → Recruiting 2025-07-16
Trial Details
NCT Number NCT07054060
Lead Sponsor Centre Hospitalier St Anne
Collaborators: Direction Générale de l'Offre de Soins
Conditions Stroke
Enrollment 600 participants
Start Date 2025-07-16
Primary Completion 2028-03-16 (estimated)
Study Completion 2028-03-16 (estimated)
Updated on ClinicalTrials.gov 2025-07-24